Checkmate Pharmaceuticals, Inc.
CMPIDelisted May 31, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001651431
Checkmate Pharmaceuticals, Inc. was delisted on May 31, 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.
Holders of 5% or more of CMPI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Checkmate Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Checkmate Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on Checkmate Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 7, 2022 | venBio Global Strategic Fund II L.P. | 13G/AOld format | – | – | – | SEC |
| Jun 7, 2022 | Gardner Lewis Asset Management L P | 13D/AOld format | – | – | – | SEC |
| Jun 3, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Jun 3, 2022 | Gardner Lewis Asset Management L P | 13DOld format | – | New | – | SEC |
| May 11, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| May 5, 2022 | venBio Global Strategic Fund II L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Clough Capital Partners L P | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Decheng Capital Management III (Cayman), LLC | 13GOld format | – | New | – | SEC |
| Nov 1, 2021 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| May 24, 2021 | Clough Capital Partners L P | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Omega Fund VI, L.P. | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Clough Capital Partners L P | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Checkmate Pharmaceuticals, Inc. shares.
No Form 144 notices for Checkmate Pharmaceuticals, Inc. are on file.